A predictive test for chemical respiratory sensitizers
GARDair is an in vitro test capable of identifying chemical respiratory sensitizers. The test provides a binary prediction, classifying the test samples as either respiratory sensitizers or non-sensitizers.
With a high specificity of 95%, GARDair is recommended for use as an R&D tool to identify and rule out respiratory sensitizers in candidate ingredients. The high specificity means that there are few false positive results (5%). If a sample is classified as a respiratory sensitizer in GARDair, you can trust the result and remove the candidate ingredient with confidence. Furthermore, unnecessary measures on falsely classified sensitizers can be avoided.
GARDair is the only available test for respiratory sensitization on the market.
DOWNLOAD PRODUCT FACTS
For R&D purposes
The number of biomarkers used in GARDair.